Skip to main content
. 2018 Jun 5;8:8637. doi: 10.1038/s41598-018-26882-8

Figure 6.

Figure 6

NNMT overexpression alters nicotinic acid metabolites and affects Sirt3/PGC-1α target genes. (A) Nicotinic acid metabolites in the livers of NMMT Tg mice (black bars) and WT littermates (white bars) on an HFD with NAM for 7 months. The data represent the means ± SEM (n = 5–6 animals/group). (B) Relative mRNA expression levels in the livers of Tg mice (black bars) and WT mice (white bars) on an HFD with NAM. (n = 5–6 per group). *P < 0.05, **P < 0.01 versus WT mice. (C) Sirt1 protein expression levels in the livers of Tg mice and WT mice on an HFD with NAM for 7 months. (D) Sirt3 activity in livers of Tg mice (black bars) and WT mice (white bars) on an HFD with NAM for 7 months. (n = 5–6 per group). *P < 0.05 versus WT mice. (E) Relative mRNA expression levels in the livers of Tg mice (black bars) and WT mice (white bars) on an HFD with NAM. (n = 5–6 per group). *P < 0.05, **P < 0.01 versus WT mice. Full-length blots/gels are presented in Supplementary Fig. 6. Abbreviations: NAM, nicotinamide; MNA, 1-methylnicotinamide; NNO, nicotinamide-N-oxide; 2PY, N-methyl-2-pyridone-5-carboxamide; 4PY, N-methyl-4-pyridone-5-carboxamide; NMN, nicotinamide mononucleotide; NAD+, nicotinamide adenine dinucleotide; HFD, high fat diet; Tg, transgenic; WT, wild type; sirt, sirtuin; PPAR, peroxisome proliferator-activated receptor; PGC-1α, peroxisome proliferator-activated receptor-gamma coactivator 1 α; Acox1, acyl-coenzyme A oxidase 1; MCAD, medium chain acyl coenzyme A dehydrogenase; LCAD, very long chain acyl coenzyme A dehydrogenase; Cpt1a, carnitine palmitoyltransferase 1A.